Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1801 AL 1815

Endoplasmic Reticulum Stress Regulators: New Drug Targets for Parkinson's Disease

Kovaleva V, Saarma M.

J Parkinsons Dis. 2021;11(s2):S219-S228. doi: 10.3233/JPD-212673.

Short-term effect and its retention of LSVT® BIG on QOL improvement: 1-year follow-up in a patient with Parkinson's disease

Hirakawa Y, Koyama S, Takeda K, Iwai M, Motoya I, Sakurai H, Kanada Y, Kawamura N, Kawamura M, Tanabe S.

NeuroRehabilitation. 2021;49(3):501-509. doi: 10.3233/NRE-210129.

Home Health Management of Parkinson Disease Deep Brain Stimulation: A Randomized Clinical Trial

Duffley G, Lutz BJ, Szabo A, Wright A, Hess CW, Ramirez-Zamora A, Zeilman P, Chiu S, Foote KD, Okun MS, Butson CR.

JAMA Neurol. 2021 Aug 1;78(8):972-981. doi: 10.1001/jamaneurol.2021.1910.

Registered report: Does transcranial direct current stimulation of the primary motor cortex improve implicit motor sequence learning in Parkinson's disease?

Firouzi M, Baetens K, Swinnen E, Baeken C, Van Overwalle F, Deroost N.

J Neurosci Res. 2021 Oct;99(10):2406-2415. doi: 10.1002/jnr.24908. Epub 2021 Jun 28.

Accurate Monitoring of Parkinson's Disease Symptoms With a Wearable Device During COVID-19 Pandemic

Tsamis KI, Rigas G, Nikolaos K, Fotiadis DI, Konitsiotis S.

In Vivo. 2021 Jul-Aug;35(4):2327-2330. doi: 10.21873/invivo.12507.

The Burden of Dementia due to Down Syndrome, Parkinson's Disease, Stroke, and Traumatic Brain Injury: A Systematic Analysis for the Global Burden of Disease Study 2019

GBD 2019 Dementia Collaborators.

Neuroepidemiology. 2021;55(4):286-296. doi: 10.1159/000515393. Epub 2021 Jun 28.

The effects of transcranial direct current stimulation on gait in patients with Parkinson's disease: a systematic review

Pol F, Salehinejad MA, Baharlouei H, Nitsche MA.

Transl Neurodegener. 2021 Jun 29;10(1):22. doi: 10.1186/s40035-021-00245-2.

[Progressive supranuclear palsy]

Fedorova NV, Bril EV, Kulua TK, Mikhaylova AD.

Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(5):111-119. doi: 10.17116/jnevro2021121051111.

[Association of polymorphic variants of DDC (AADC), AANAT and ASMT genes encoding enzymes for melatonin synthesis with the higher risk of neuropsychiatric disorders]

Moskaleva PV, Shnayder NA, Nasyrova RF.

Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(5):151-157. doi: 10.17116/jnevro2021121041151.

Yoga Interventions Used for the Rehabilitation of Stroke, Parkinson's Disease, and Multiple Sclerosis: A Scoping Review of Clinical Research

Legault Z, Znaty A, Smith S, Boudrias MH.

J Altern Complement Med. 2021 Dec;27(12):1023-1057. doi: 10.1089/acm.2021.0003. Epub 2021 Jun 29.

The landmark contributions of Paul Blocq, Georges Marinesco, and Édouard Brissaud in Parkinson's disease

Fénelon G, Walusinski O.

Rev Neurol (Paris). 2021 Dec;177(10):1214-1220. doi: 10.1016/j.neurol.2021.02.386. Epub 2021 Jun 27.

Methodological considerations of evaluating the rate of presynaptic dopaminergic denervation in Parkinson disease with radiotracers: Analysis of the PPMI data

Lee JW, Song YS, Kim H, Ku BD, Lee WW.

Medicine (Baltimore). 2021 Jul 2;100(26):e26534. doi: 10.1097/MD.0000000000026534.

Parkinsonism-hyperpyrexia Syndrome After Amantadine Withdrawal: Case Report and Review of the Literature

Dos Santos DT, Imthon AK, Strelow MZ, Pille A, Schumacher-Schuh AF.

Neurologist. 2021 Jul 6;26(4):149-152. doi: 10.1097/NRL.0000000000000330.

Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial

Videnovic A, Amara AW, Comella C, Schweitzer PK, Emsellem H, Liu K, Sterkel AL, Gottwald MD, Steinerman JR, Jochelson P, Zomorodi K, Hauser RA.

Mov Disord. 2021 Oct;36(10):2408-2412. doi: 10.1002/mds.28702. Epub 2021 Jun 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias